|
1
|
Congdon NG, Friedman DS and Lietman T:
Important causes of visual impairment in the world today. Jama.
290:2057–2060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Laiginhas R, Madeira C, Lopes M, Neves JN,
Barbosa M, Rosas V, Carvalho D, Falcão-Reis F and Falco M: Risk
factors for prevalent diabetic retinopathy and proliferative
diabetic retinopathy in type 1 diabetes. Endocrine. 66:201–209.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dong C, Liu P, Wang H, Dong M, Li G and Li
Y: Ginsenoside Rb1 attenuates diabetic retinopathy in
streptozotocin-induced diabetic rats1. Acta Cir Bras.
34:e2019002012019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeganathan VS, Wang JJ and Wong TY: Ocular
associations of diabetes other than diabetic retinopathy. Diabetes
Care. 31:1905–1912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dehdashtian E, Mehrzadi S, Yousefi B,
Hosseinzadeh A, Reiter RJ, Safa M, Ghaznavi H and Naseripour M:
Diabetic retinopathy pathogenesis and the ameliorating effects of
melatonin; involvement of autophagy, inflammation and oxidative
stress. Life Sci. 193:20–33. 2018. View Article : Google Scholar
|
|
6
|
Abougalambou SS and Abougalambou AS: Risk
factors associated with diabetic retinopathy among type 2 diabetes
patients at teaching hospital in Malaysia. Diabetes Metab Syndr.
9:98–103. 2015. View Article : Google Scholar
|
|
7
|
Rubsam A, Parikh S and Fort PE: Role of
inflammation in diabetic retinopathy. Int J Mol Sci. 19:9422018.
View Article : Google Scholar :
|
|
8
|
Wang H, Wang G, Liang Y, Du X, Boor PJ,
Sun J and Khan MF: Redox regulation of hepatic NLRP3 inflammasome
activation and immune dysregulation in trichloroethene-mediated
autoimmunity. Free Rad Biol Med. 143:223–231. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen H, Zhang X, Liao N, Mi L, Peng Y, Liu
B, Zhang S and Wen F: Enhanced expression of NLRP3
inflammasome-related inflammation in diabetic retinopathy. Invest
Ophthalmol Vis Sci. 59:978–985. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chaurasia SS, Lim RR, Parikh BH, Wey YS,
Tun BB, Wong TY, Luu CD, Agrawal R, Ghosh A, Mortellaro A, et al:
The NLRP3 inflammasome may contribute to pathologic
neovascularization in the advanced stages of diabetic retinopathy.
Sci Rep. 8:28472018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guigui S, Lifshitz T and Levy J: Diabetic
retinopathy in Africa: Advantages of screening. Postgrad Med.
123:119–125. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nomura K, Lee M, Banks C, Lee G and Morris
BJ: An ASK1-p38 signalling pathway mediates hydrogen
peroxide-induced toxicity in NG108-15 neuronal cells. Neurosci
Lett. 549:163–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sobhan PK, Zhai Q, Green LC, Hansford LM
and Funa K: ASK1 regulates the survival of neuroblastoma cells by
interacting with TLX and stabilizing HIF-1α. Cell Signal.
30:104–117. 2017. View Article : Google Scholar
|
|
14
|
Katome T, Namekata K, Guo X, Semba K,
Kittaka D, Kawamura K, Kimura A, Harada C, Ichijo H, Mitamura Y and
Harada T: Inhibition of ASK1-p38 pathway prevents neural cell death
following optic nerve injury. Cell Death Differ. 20:270–280. 2013.
View Article : Google Scholar :
|
|
15
|
Flaumenhaft R: Stressed platelets ASK1 for
a MAPK. Blood. 129:1066–1068. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang C, Zhu HJ, Li H, Li QX, Li FM, Cheng
L and Liu YG: P38-MAPK pathway is activated in retinopathy of
microvascular disease of STZ-induced diabetic rat model. Eur Rev
Med Pharmacol Sci. 22:5789–5796. 2018.PubMed/NCBI
|
|
17
|
Fortin J, Patenaude A, Deschesnes RG, Côté
MF, Petitclerc E and C-Gaudreault R: ASK1-P38 pathway is important
for anoikis induced by microtubule-targeting aryl chloroethylureas.
J Pharm Pharm Sci. 13:175–190. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barros-Miñones L, Orejana L, Goñi-Allo B,
Suquía V, Hervías I, Aguirre N and Puerta E: Modulation of the
ASK1-MKK3/6-p38/MAPK signalling pathway mediates silde-nafil
protection against chemical hypoxia caused by malonate. Br J
Pharmacol. 168:1820–1834. 2013. View Article : Google Scholar
|
|
19
|
Liu W, Gu J, Qi J, Zeng XN, Ji J, Chen ZZ
and Sun XL: Lentinan exerts synergistic apoptotic effects with
paclitaxel in A549 cells via activating ROS-TXNIP-NLRP3
inflammasome. J Cell Mol Med. 19:1949–1955. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang N, Zhang C, Xu Y, Li S, Tan HY, Xia W
and Feng Y: OMICs approaches-assisted identification of
macrophages-derived MIP-1γ as the therapeutic target of botanical
products TNTL in diabetic retinopathy. Cell Commun Signal.
17:812019. View Article : Google Scholar
|
|
21
|
Mengual L and Olivan M: Quantitative RNA
analysis from urine using real time PCR. Methods Mol Biol.
1655:227–237. 2018. View Article : Google Scholar
|
|
22
|
Klein R, Lee KE, Knudtson MD, Gangnon RE
and Klein BE: Changes in visual impairment prevalence by period of
diagnosis of diabetes: The wisconsin epidemiologic study of
diabetic retinopathy. Ophthalmology. 116:1937–1942. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wilkinson CP, Ferris FL III, Klein RE, Lee
PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R,
Verdaguer JT, Global Diabetic Retinopathy and Project Group:
Proposed international clinical diabetic retinopathy and diabetic
macular edema disease severity scales. Ophthalmology.
110:1677–1682. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang EY, Chen TH, Garg SJ, Sun CC, Kang
JH, Wu WC, Hung MJ, Lai CC, Cherng WJ and Hwang YS: Association of
statin therapy with prevention of vision-threatening diabetic
retinopathy. JAMA Ophthalmol. 137:363–371. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lowry F: Compound could help diabetic
patients walk tightrope between heperglycemia, hypoglycemia. CMAJ.
154:705–707. 1996.PubMed/NCBI
|
|
26
|
Li S, Yang H and Chen X: Protective
effects of sulforaphane on diabetic retinopathy: Activation of the
nrf2 pathway and inhibition of NLRP3 inflammasome formation. Exp
Anim. 68:221–231. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fouad AA, Abdel-Aziz AM and Hamouda AA:
Diacerein down-regulates NLRP3/Caspase-1/IL-1β and IL-6/STAT3
pathways of inflammation and apoptosis in a rat model of cadmium
testicular toxicity. Biol Trace Elem Res. 195:499–505. 2019.
View Article : Google Scholar
|
|
28
|
Tartey S and Kanneganti TD: Differential
role of the NLRP3 inflammasome in infection and tumorigenesis.
Immunology. 156:329–338. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ju A, Cho YC, Kim BR, Park SG, Kim JH, Kim
K, Lee J, Park BC and Cho S: Scaffold role of DUSP22 in
ASK1-MKK7-JNK signaling pathway. PLoS One. 11:e01642592016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iriyama T, Takeda K, Nakamura H, Morimoto
Y, Kuroiwa T, Mizukami J, Umeda T, Noguchi T, Naguro I, Nishitoh H,
et al: ASK1 and ASK2 differentially regulate the counteracting
roles of apoptosis and inflammation in tumorigenesis. EMBO J.
28:843–853. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang D, Liu X, Xu W, Gu Z, Yang C, Zhang
L, Tan J, Zheng X, Wang Z, Quan S, et al: The edwardsiella
piscicida thioredoxin-like protein inhibits ASK1-MAPKs signaling
cascades to promote pathogenesis during infection. PLoS Pathog.
15:e10079172019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong X, Duan Y, Zheng J, Wang Y, Wang G,
Norgren S and Hei TK: Nephroprotective effects of n-acetylcysteine
amide against contrast-induced nephropathy through upregulating
thioredoxin-1, Inhibiting ASK1/p38MAPK pathway, and suppressing
oxidative stress and apoptosis in rats. Oxid Med Cell Longev.
2016:87151852016. View Article : Google Scholar
|
|
33
|
Ren X, Sun H, Zhang C, Li C, Wang J, Shen
J, Yu D and Kong L: Protective function of pyridoxamine on retinal
photoreceptor cells via activation of the pErk1/2/Nrf2/Trx/ASK1
signalling pathway in diabetic mice. Mol Med Rep. 14:420–424. 2016.
View Article : Google Scholar : PubMed/NCBI
|
